Nano Dimension Ltd.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
NNDM$1.32+5.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 (Unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data) (Unaudited)
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $355,278 | $204,672 |
| Bank deposits | 8,781 | 168,997 |
| Marketable equity securities | 75,719 | 84,154 |
| Restricted bank deposits | 594 | 123 |
| Trade receivables, net of allowance for doubtful accounts ($939 and $861, respectively) | 22,700 | 26,047 |
| Inventory | 31,703 | 32,878 |
| Other current assets | 10,622 | 8,938 |
| Total current assets | 505,397 | 525,809 |
| Restricted bank deposits | 1,254 | 1,610 |
| Property, plant and equipment, net | 23,621 | 24,840 |
| Operating lease right-of-use assets | 22,487 | 23,789 |
| Deferred tax assets | 424 | 424 |
| Goodwill | — | 40,388 |
| Intangible assets, net | 18,313 | 19,434 |
| Other assets | 1,711 | 1,930 |
| Total assets | $573,207 | $638,224 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Trade payables | $12,974 | $11,999 |
| Accrued liabilities | 21,083 | 19,514 |
| Deferred revenue | 13,250 | 11,873 |
| Current portion of lease liability | 8,604 | 8,923 |
| Current portion of bank loan | 156 | 158 |
| Total current liabilities | 56,067 | 52,467 |
| Employee benefits | 3,666 | 3,697 |
| Operating lease right-of-use liabilities | 21,563 | 23,323 |
| Bank loan | 117 | 158 |
| Long-term settlement payable | 3,124 | 2,974 |
| Long-term deferred revenue | 3,226 | 3,617 |
| Total liabilities | 87,763 | 86,236 |
| Commitments and contingencies (Note 11) | ||
| Equity: | ||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 207,986,287 and 206,811,875 shares outstanding as of March 31, 2026 and December 31, 2025, respectively, and 280,480,934 and 279,306,522 shares issued as of March 31, 2026 and December 31, 2025, respectively. | 418,969 | 417,084 |
| Additional paid-in capital | 1,298,363 | 1,297,323 |
| Treasury stock | (192,507) | (192,507) |
| Accumulated other comprehensive income | 1,241 | 1,048 |
| Accumulated loss | (1,040,622) | (970,960) |
| Total equity | 485,444 | 551,988 |
| Total liabilities and equity | $573,207 | $638,224 |
| See Notes to Condensed Consolidated Financial Statements. | ||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In thousands, except share data) (Unaudited)
| Three months ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Revenue: | ||
| Product | $22,931 | $11,679 |
| Service | 6,794 | 2,722 |
| Total revenue | 29,725 | 14,401 |
| Cost of revenue: | ||
| Product | 14,222 | 7,081 |
| Service | 3,376 | 1,479 |
| Total cost of revenue | 17,598 | 8,560 |
| Gross profit | 12,127 | 5,841 |
| Operating expenses: | ||
| Research and development | 8,204 | 5,944 |
| Sales and marketing | 9,692 | 5,644 |
| General and administrative | 15,209 | 5,667 |
| Restructuring | 3,127 | 1,180 |
| Desktop Metal litigation | — | 28,069 |
| Impairment losses | 40,388 | 1,229 |
| Operating loss | (64,493) | (41,892) |
| (Loss) gain on investment in marketable equity securities | (8,435) | 8,726 |
| Finance income | 3,512 | 9,320 |
| Finance expense | (246) | (1,679) |
| Loss before income taxes | (69,662) | (25,525) |
| Income tax expense | — | (23) |
| Net loss | (69,662) | (25,548) |
| Less: Net loss attributable to non-controlling interests | — | (236) |
| Net loss attributable to common shareholders | $(69,662) | $(25,312) |
| Net loss attributable to common shareholders: | ||
| Basic and diluted | $(0.34) | $(0.12) |
| Weighted average common shares outstanding, basic and diluted | 207,504 | 216,462 |
| Net loss | $(69,662) | $(25,548) |
| Other comprehensive income: | ||
| Foreign currency translation adjustment | 193 | 593 |
| Comprehensive loss | (69,469) | (24,955) |
| Less: Comprehensive loss attributable to non-controlling interests | — | (224) |
| Comprehensive loss attributable to common shareholders | $(69,469) | $(24,731) |
| See Notes to Condensed Consolidated Financial Statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.